Through model interpretation and biological experimental validation, we identified three novel breast cancer genes—PCDHA10, PRICKLE2, and PRTG—demonstrating their inhibitory effects on cell proliferation and migration in breast cancer cell lines. This evidence concerns the gene PRICKLE2 and breast carcinoma.